GBA Fund | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,162 results for “GBA Fund”

OncoC4 Secures $50 Million Series B Funding to Advance Immuno-Oncology Pipeline

GenEditBio Secures Investment to Advance Genome Editing Technologies

Bial's BIA 28-6156 Reaches Key Milestone in Phase 2 Trial for GBA-Associated Parkinson's Disease

Vanqua Bio's VQ-101 Achieves Over 70% GCase Activation in Phase 1b Trial for GBA-Parkinson's Disease

VQ-101 Shows Promise in Phase 1 Trial for GBA-Parkinson's Disease

Dementia Discovery Fund Secures $269M in Second Fund to Accelerate Novel Therapeutics Development

BIAL Doses First Patient in Phase 2 Trial of BIA 28-6156 for GBA-Related Parkinson's Disease

BIAL's BIA 28-6156 Phase 2 Trial Reaches Milestone with First Patient Completion

Bial's Phase 2b ACTIVATE Study Reaches 75% Completion Milestone for GBA1-Associated Parkinson's Disease Treatment

CAP-003 Gene Therapy Shows Promise for Parkinson's Disease with GBA Mutations

Page 1 of 221